Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The study is designed to assess the efficacy, safety, tolerability, and transformation within
the human body of INV-202 investigational drug in the treatment of adult participants with
obesity and metabolic syndrome.